The National Institutes of Health (NIH) has released the results of TACT (Trail to Assess Chelation Therapy), a study that began in 2003. People in the trial who received chelation therapy had decreased hospitalizations for angina, compared to the control group and there were fewer deaths from heart attacks and strokes for the patients receiving chelation therapy. The chelation patients also needed less bypass surgeries and angioplasties. The findings were especially positive for patients who also suffered from diabetes: chelation therapy reduced cardiac events by 18% and by 39% for diabetic patients. The total reduction in cardiac events was statistically significant. Physicians conducting the study included university cardiologists and experienced chelation physicians.

Dr. Conrad G. Maulfair, Jr., of Maulfair Medical Center, is not surprised by the findings. “I have been providing chelation therapy to my patient family and continued my own chelation program for over 35 years,” he says. “I know the benefits. I see peripheral vascular disease, heart disease, high blood pressure and diabetes abate all the time. Some of our diabetic patients no longer require insulin injections.”

Study results compliments of Maulfair Medical Center, located at 2970 Corporate Court, Orefield. For more information or to schedule a consultation, call 610-682-2104.